MISSISSAUGA, ON, May 31, 2016 /PRNewswire/ - Cipher
Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the
Company") today announced that Shawn
Patrick O'Brien, President and Chief Executive Officer, will
present at two upcoming investor conferences.
- Jefferies 2016 Healthcare Conference in New York on June
10 at 8:30 a.m. ET.
- JMP Securities 2016 Life Sciences Conference in New York on June
22 at 2:00 p.m. ET.
Both conference presentations will be webcast live. To access
the webcasts, please go to the Investors section of Cipher's
website at www.cipherpharma.com under the Events and Webcasts
tab.
About Cipher Pharmaceuticals Inc.
Cipher
Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly growing
specialty pharmaceutical dermatology company with a diversified
portfolio of commercial-stage products with the goal of becoming
the most customer-centric dermatology company in North America.
Cipher completed seven transactions in 2015, including the
acquisition of Innocutis and its nine branded dermatology products,
to build its U.S. commercial presence, expand its Canadian
dermatology franchise and broaden its pipeline. Cipher is
well-capitalized to drive long-term, sustained earnings growth by
leveraging its proven clinical development capabilities and
efficient commercial execution. For more information, visit
www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.